PCR cycles above routine numbers do not compromise high-throughput DNA barcoding results.

Genome

b Department of Evolutionary Ecology, Estación Biológica de Doñana (CSIC), Avenida Américo Vespucio s/n. E-41092 Sevilla, Spain.

Published: October 2017

AI Article Synopsis

  • High-throughput DNA barcoding is important for ecology and evolution, but the impact of increased PCR cycles on mutation rates is unclear.
  • Researchers sequenced 20 COI libraries from cephalopods using varying PCR cycles (40-60) and found no significant relationship between cycle number and mutation rates, even with a nonproofreading polymerase.
  • The findings suggest that increasing PCR cycles does not adversely affect the reliability of high-throughput DNA barcoding in terms of point mutations, though caution is needed for applications like DNA metabarcoding due to potential chimera formation.

Article Abstract

High-throughput DNA barcoding has become essential in ecology and evolution, but some technical questions still remain. Increasing the number of PCR cycles above the routine 20-30 cycles is a common practice when working with old-type specimens, which provide little amounts of DNA, or when facing annealing issues with the primers. However, increasing the number of cycles can raise the number of artificial mutations due to polymerase errors. In this work, we sequenced 20 COI libraries in the Illumina MiSeq platform. Libraries were prepared with 40, 45, 50, 55, and 60 PCR cycles from four individuals belonging to four species of four genera of cephalopods. We found no relationship between the number of PCR cycles and the number of mutations despite using a nonproofreading polymerase. Moreover, even when using a high number of PCR cycles, the resulting number of mutations was low enough not to be an issue in the context of high-throughput DNA barcoding (but may still remain an issue in DNA metabarcoding due to chimera formation). We conclude that the common practice of increasing the number of PCR cycles should not negatively impact the outcome of a high-throughput DNA barcoding study in terms of the occurrence of point mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1139/gen-2017-0081DOI Listing

Publication Analysis

Top Keywords

pcr cycles
24
high-throughput dna
16
dna barcoding
16
number pcr
16
increasing number
12
cycles routine
8
number
8
common practice
8
cycles number
8
number mutations
8

Similar Publications

Background: To date, there remains a paucity of comparative investigations pertaining to preoperative immunochemotherapy and conventional chemotherapy in the context of limited-stage small-cell lung cancer (LS-SCLC) patients. This study conducted a comprehensive comparative assessment concerning the safety and efficacy profiles of preoperative immunochemotherapy and chemotherapy in individuals diagnosed with stage I-IIIB SCLC.

Methods: This investigation collected 53 consecutive patients diagnosed with LS-SCLC spanning stage I to IIIB who underwent preoperative immunochemotherapy or conventional chemotherapy at our hospital from January 2019 to July 2021.

View Article and Find Full Text PDF

Glioblastoma is considered the most malignant central nervous system tumor. This study aimed to investigate effects of latent transforming growth factor-β binding protein-2 (LTBP2) on glioblastoma growth and associated mechanisms. LTBP2 gene transcription in glioblastoma was determined using RT-PCR.

View Article and Find Full Text PDF

SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma.

Int J Oncol

February 2025

Department of Burn and Plastic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China.

Plexiform neurofibromas (PNFs) are benign tumors that affect 20‑50% of patients with type I neurofibromatosis (NF1). PNF carries a risk of malignancy. There is no effective cure for PNF.

View Article and Find Full Text PDF

Wilms tumor 1-associated protein (WTAP) has been validated to be a crucial regulator in the tumorigenesis and advancement of diverse malignancies. This study intended to probe the impacts of WTAP on colorectal cancer (CRC) progression from the perspective of N6-methyladenosine (m6A) modification. The differential expression patterns of WTAP in clinical CRC samples and cultured cell lines were validated via qRT-PCR and western blot.

View Article and Find Full Text PDF

Introduction: Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) therapy is indicated as first-line or neoadjuvant chemotherapy (NAC) for patients with advanced or metastatic urothelial carcinoma (UC). However, no studies reported ddMVAC therapy with pegfilgrastim (3.6 mg) in Japanese patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!